10/06/2005 (Agence Europe) - The fifteen patient associations DEBRA Europe (skin diseases), EAMDA (neuro-muscular disorders), ECPP (HIV/AIDS), ECFPN (cystic fibrosis), EDF (dystonia), EFCCA (Crohn's disease), EGAN (genetic diseases), EHC (haemophilia), EUFAMI (mental illness), Euro-Ataxia (ataxia), HEART EU (heart disease), IDF/Europe (diabetes), Retina Europe, VGPN (disability) and EURORDIS (rare illnesses) have signed a declaration in which they "strongly support the system of fixed recompense and obligations upon pharmaceutical companies to develop safe medicines for children". As the Commission's proposal provides, procedures must be clear, or short and efficient, the 15 patient organisations add.